The Latest
Business
The Fine for Fake Paneer Costs Less Than Amul Earns in a Minute
FSSAI's new draft rule reserves the word paneer for milk-derived products. The fine for breaking it hasn't moved since 2006, and it is smaller than a minute of Amul's revenue.
September 25, 2026
Geopolitics
How India's Chief Election Commissioner Bypassed His Own Commission 14 Times
Two of the Election Commission's three members formally objected to fourteen orders issued by the Chief Election Commissioner over ten months. The law says such disagreements are settled by majority vote, not by one man, and that claim is now before two courts.
September 25, 2026
Science
96 Percent of Orbital Collision Risk Comes From Junk, Not New Satellites
ESA's newest debris count shows that almost all of low Earth orbit's collision risk comes from hardware nobody controls anymore. ISRO's satellites, and India's own new constellations, are the ones now dodging it.
September 25, 2026
Business
The IIT Placement Ban Assumes Companies Still Want to Hire
IITs just barred 22 companies from campus hiring for two years. The ban only works if those companies still want to come back, and corporate hiring itself is slowing.
September 25, 2026
Health
India Approved Dementia Drugs Most Hospitals Cannot Monitor
India's regulator has cleared two Alzheimer's drugs that can slow the disease. Most dementia patients are in the wrong stage to get them, and most hospitals lack the scans to give them safely.
September 24, 2026
Business
PB Fintech's Stock Crash Shows Its Premium Was Never About Technology
A regulatory paper on insurance commissions wiped a fifth off PB Fintech's stock in a single session, exposing how much of its business was commission, not technology.
September 24, 2026
Business & Markets
Business
The Fine for Fake Paneer Costs Less Than Amul Earns in a Minute
FSSAI's new draft rule reserves the word paneer for milk-derived products. The fine for breaking it hasn't moved since 2006, and it is smaller than a minute of Amul's revenue.
September 25, 2026
Business
The IIT Placement Ban Assumes Companies Still Want to Hire
IITs just barred 22 companies from campus hiring for two years. The ban only works if those companies still want to come back, and corporate hiring itself is slowing.
September 25, 2026
Business
PB Fintech's Stock Crash Shows Its Premium Was Never About Technology
A regulatory paper on insurance commissions wiped a fifth off PB Fintech's stock in a single session, exposing how much of its business was commission, not technology.
September 24, 2026
Technology & Science
Technology
RatHat Steals Bank PINs Without Ever Touching the OTP
A new Android banking trojan reads PINs straight off the screen using the accessibility tool built for blind users. India's OTP defense never even sees it.
September 22, 2026
Technology
India's Semiconductor Success Turned It Into a Sabotage Target
ASML confirmed it has started operating in India the same week its minister warned the chip industry to brace for cyberattacks. The mission's success, not despite it, is what created the target.
September 21, 2026
Technology
The Lawsuit That Says AI Labs Colluded by Trying to Be Safe
Four subscribers say Anthropic, OpenAI, SpaceXAI and Google's joint safety pledge was an illegal slowdown pact. The case lands in a regulatory vacuum antitrust law never filled.
September 20, 2026
Health, Culture & Geopolitics
Health
Many Common Surgeries Work No Better Than a Fake Operation
A new review of sham-controlled surgical trials found most show no benefit over a fake operation. It is the same finding research has made for two decades, and it collides with India's insurance-driven appetite for elective surgery.
September 25, 2026
Health
India Approved Dementia Drugs Most Hospitals Cannot Monitor
India's regulator has cleared two Alzheimer's drugs that can slow the disease. Most dementia patients are in the wrong stage to get them, and most hospitals lack the scans to give them safely.
September 24, 2026
Health
The Cancer Drug Price Cap That Covers Only 42 Medicines
The Supreme Court just called a tenfold cancer-drug markup 'dacoity, broad daylight dacoity.' India built a price cap for exactly this problem in 2019, and it still only reaches 42 named drugs.
September 23, 2026